DOMINICI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 45.023
AS - Asia 23.135
EU - Europa 22.878
SA - Sud America 3.384
Continente sconosciuto - Info sul continente non disponibili 787
AF - Africa 586
OC - Oceania 117
Totale 95.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.908
SG - Singapore 6.884
IT - Italia 6.570
CN - Cina 5.716
GB - Regno Unito 4.890
SE - Svezia 3.433
HK - Hong Kong 2.726
VN - Vietnam 2.558
BR - Brasile 2.463
DE - Germania 2.038
BD - Bangladesh 1.297
FI - Finlandia 1.109
RU - Federazione Russa 934
FR - Francia 795
KR - Corea 703
TR - Turchia 619
UA - Ucraina 613
CA - Canada 612
IN - India 551
IE - Irlanda 538
ID - Indonesia 502
AR - Argentina 326
NL - Olanda 325
MX - Messico 299
JP - Giappone 296
BG - Bulgaria 292
ES - Italia 187
PL - Polonia 187
ZA - Sudafrica 172
BE - Belgio 171
IQ - Iraq 171
PK - Pakistan 144
AT - Austria 126
AE - Emirati Arabi Uniti 121
EC - Ecuador 117
AU - Australia 111
CO - Colombia 109
CL - Cile 105
VE - Venezuela 104
MY - Malesia 96
LT - Lituania 92
CZ - Repubblica Ceca 85
RO - Romania 81
MA - Marocco 75
UZ - Uzbekistan 68
KE - Kenya 67
TW - Taiwan 65
PH - Filippine 64
CH - Svizzera 62
EG - Egitto 62
IR - Iran 60
SA - Arabia Saudita 57
JO - Giordania 54
PE - Perù 51
PY - Paraguay 48
AL - Albania 46
DZ - Algeria 44
IL - Israele 44
NO - Norvegia 44
TN - Tunisia 43
TH - Thailandia 40
NP - Nepal 36
PT - Portogallo 34
SI - Slovenia 30
UY - Uruguay 30
CR - Costa Rica 28
AZ - Azerbaigian 27
JM - Giamaica 27
LB - Libano 27
RS - Serbia 26
KZ - Kazakistan 25
DO - Repubblica Dominicana 24
BO - Bolivia 23
OM - Oman 23
BY - Bielorussia 22
DK - Danimarca 19
HR - Croazia 19
SY - Repubblica araba siriana 19
ET - Etiopia 18
GR - Grecia 18
SN - Senegal 18
HN - Honduras 17
EU - Europa 16
QA - Qatar 16
SK - Slovacchia (Repubblica Slovacca) 16
CY - Cipro 15
GT - Guatemala 14
NG - Nigeria 14
PA - Panama 14
BZ - Belize 13
EE - Estonia 13
HU - Ungheria 13
AM - Armenia 12
CI - Costa d'Avorio 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
SV - El Salvador 12
GE - Georgia 11
PR - Porto Rico 11
BA - Bosnia-Erzegovina 10
Totale 94.916
Salva come PNG Salva come JPEG
Città #
Ashburn 4.950
Singapore 4.375
Santa Clara 3.939
Fairfield 3.776
Southend 2.704
Hong Kong 2.644
Chandler 2.271
Woodbridge 1.979
San Jose 1.942
Stockholm 1.834
Hefei 1.775
Houston 1.599
Seattle 1.379
Wilmington 1.199
Cambridge 1.174
Council Bluffs 1.140
Ann Arbor 1.111
Beijing 1.059
London 1.049
Los Angeles 1.014
Nyköping 974
Jacksonville 960
Ho Chi Minh City 860
Chicago 858
New York 854
Dearborn 846
Helsinki 835
Modena 723
Seoul 656
Hanoi 612
Dallas 600
The Dalles 584
Milan 559
Munich 524
Bologna 507
Dublin 500
San Diego 432
Jakarta 361
Salt Lake City 319
Lauterbourg 317
Buffalo 307
Izmir 307
Princeton 303
Moscow 293
Shanghai 285
Sofia 276
Rome 267
Frankfurt am Main 242
São Paulo 224
Tokyo 216
Eugene 197
Orem 184
Boardman 172
Phoenix 165
Parma 157
Tampa 153
Elk Grove Village 150
Reggio Emilia 141
Warsaw 137
Toronto 136
Columbus 132
Redwood City 129
Berlin 127
Des Moines 125
Montreal 123
Brussels 122
Mexico City 121
Atlanta 119
Falls Church 119
Nuremberg 119
Bremen 114
Mcallen 109
Fremont 108
Guangzhou 108
Da Nang 105
Naples 105
Chennai 103
Montréal 103
Brooklyn 102
Amsterdam 101
Denver 101
Johannesburg 101
Rio de Janeiro 97
Lancaster 95
Haiphong 88
Kent 87
Manchester 86
Florence 82
Miami 79
Redondo Beach 76
Sterling 71
San Francisco 64
Turku 64
Poplar 63
Vienna 63
Portsmouth 61
Dong Ket 60
Hillsboro 60
Mumbai 60
Baghdad 59
Totale 63.917
Salva come PNG Salva come JPEG
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.216
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 721
Dynamic cultivation of mesenchymal stem cell aggregates 657
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 593
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 503
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 478
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 476
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 435
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 431
GD2 expression in breast cancer. 427
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 427
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 426
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 423
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 422
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 409
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 409
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 407
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 406
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 400
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 397
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 395
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 393
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 392
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 391
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 387
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 385
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 385
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 381
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 380
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 380
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells 378
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 377
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 375
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 370
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 370
A novel function for amniotic fluid: original or authentic? 368
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 365
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 365
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 362
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 357
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 356
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 356
Clarification of the nomenclature for MSC: the international society for cellular therapy position statement 354
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 354
An alternative approach to investigate biofilm in medical devices: A feasibility study 352
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 348
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 346
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 345
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 344
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 341
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 341
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 340
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 338
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 338
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 337
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 336
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 335
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 335
Tumor Stroma Manipulation By MSC 334
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 333
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 333
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 331
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 330
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 325
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 324
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 324
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 321
A new bioactive glass with extremely high crystallization temperature and outstanding biological performance 321
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 320
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 320
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 319
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 317
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 317
Assessing biocompatibility of face mask materials during covid-19 pandemic by a rapid multi-assays strategy 317
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 316
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 315
Detection of microparticles from human red blood cells by multiparametric flow cytometry 315
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 314
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 313
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 313
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 309
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 308
The phenotypes of microglia and macrophages during epileptogenesis 307
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 306
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 305
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 305
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. 304
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 304
Transgenic Mice with Pancellular Enhanced Green Fluorescent Protein Expression in Primitive Hematopoietic Cells and All Blood Cell Progeny 303
How do mesenchymal stromal cells exert their therapeutic benefit? 302
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 301
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning 299
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany 299
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 299
Cell therapies for pancreatic beta-cell replenishment. 298
Cell therapy for disorders of bone 298
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 297
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 296
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 295
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 294
Totale 37.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 371.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 371.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.632 365 732 580 346 281 473 400 409 648 522 1.072 804
2022/20237.282 818 781 539 662 740 904 188 654 1.158 135 404 299
2023/20245.108 257 309 365 493 817 499 512 599 154 196 287 620
2024/202516.755 493 224 488 1.141 2.682 2.476 1.410 980 1.958 1.128 1.615 2.160
2025/202638.311 2.329 1.396 3.035 4.275 5.747 2.164 4.219 1.798 5.050 3.546 2.698 2.054
2026/20271.058 1.058 0 0 0 0 0 0 0 0 0 0 0
Totale 95.910